{"entity":{"id":"idea-bio2-rare-cancer-telepathology-network","kind":"idea","name":"A same-week expert second opinion for every rare cancer diagnosis","aka":[],"tldr":"Rare cancers are often misdiagnosed, which sends patients down the wrong treatment path. Digital slide sharing could get every case to an expert within days.","summary":"Reference pathology review changes the diagnosis in a substantial minority of sarcoma and rare tumour cases, and diagnosis determines treatment entirely. European reference networks and national sarcoma review panels show the model works, but coverage is incomplete and turnaround is slow. Whole-slide imaging plus a funded expert rota plus AI pre-screening for likely rare entities would make it universal.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Rare and paediatric cancers without markets): Gatta et al., Rare cancers are not so rare: the rare cancer burden in Europe (EJC 2011)","url":"https://doi.org/10.1016/j.ejca.2011.08.008"}],"tags":[],"related":[],"cancers":["sarcoma","neuroendocrine","thyroid"],"sections":[],"technologies":["digital-pathology-ai","pathology-foundation-model","histopathology-ihc"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["sarcoma-histotype-tailoring"],"trials":[],"people":["alessandro-gronchi","jean-yves-blay","marco-guzzo"],"bottlenecks":["b-rare-cancers","b-care-fragmentation","b-workforce"],"keyPapers":["paper-gatta-eur-j-cancer"],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Mandatory digital reference review for suspected rare cancers changes diagnosis or management in at least 15% of cases and improves guideline-concordant treatment, with median turnaround under seven days.","rationale":"Centralised review already improves outcomes in sarcoma when patients are managed in reference centres. Digital pathology removes the physical slide logistics that limited previous schemes, and AI triage can flag which cases need expert eyes.","test":"A regional programme with mandatory digital review for a defined list of rare diagnoses, reporting diagnostic change rate, turnaround and downstream treatment concordance.","maturity":"being-tested-at-scale","actor":"clinic","cost":"medium","horizonYears":4},"route":"/ideas/idea-bio2-rare-cancer-telepathology-network/","neighbours":{"cancer":[{"id":"neuroendocrine","kind":"cancer","name":"Neuroendocrine tumours","route":"/cancers/neuroendocrine/"},{"id":"sarcoma","kind":"cancer","name":"Sarcomas (soft tissue, bone, GIST)","route":"/cancers/sarcoma/"},{"id":"thyroid","kind":"cancer","name":"Thyroid cancer","route":"/cancers/thyroid/"}],"technology":[{"id":"digital-pathology-ai","kind":"technology","name":"Digital pathology & AI","route":"/technologies/digital-pathology-ai/"},{"id":"histopathology-ihc","kind":"technology","name":"Histopathology & immunohistochemistry","route":"/technologies/histopathology-ihc/"},{"id":"pathology-foundation-model","kind":"technology","name":"Pathology & radiology foundation models","route":"/technologies/pathology-foundation-model/"}],"term":[{"id":"sarcoma-histotype-tailoring","kind":"term","name":"Histotype-tailored therapy","route":"/terms/sarcoma-histotype-tailoring/"}],"person":[{"id":"alessandro-gronchi","kind":"person","name":"Alessandro Gronchi","route":"/people/alessandro-gronchi/"},{"id":"jean-yves-blay","kind":"person","name":"Jean-Yves Blay","route":"/people/jean-yves-blay/"},{"id":"marco-guzzo","kind":"person","name":"Marco Guzzo","route":"/people/marco-guzzo/"}],"bottleneck":[{"id":"b-care-fragmentation","kind":"bottleneck","name":"Fragmented care and guideline gaps","route":"/bottlenecks/b-care-fragmentation/"},{"id":"b-workforce","kind":"bottleneck","name":"Not enough oncologists, nurses, pathologists, physicists","route":"/bottlenecks/b-workforce/"},{"id":"b-rare-cancers","kind":"bottleneck","name":"Rare and paediatric cancers without markets","route":"/bottlenecks/b-rare-cancers/"}],"paper":[{"id":"paper-gatta-eur-j-cancer","kind":"paper","name":"Rare cancers are not so rare: the rare cancer burden in Europe","route":"/key-papers/paper-gatta-eur-j-cancer/"}]}}